1693 related articles for article (PubMed ID: 6831652)
41. Influence of nifedipine, verapamil and diltiazem on pulmonary vascular resistance and vasoconstrictors in cats.
Erdemli O; Hao Q; Cai B; Lippton HL; Hyman A
Arch Int Pharmacodyn Ther; 1994; 328(2):165-79. PubMed ID: 7535994
[TBL] [Abstract][Full Text] [Related]
42. [Calcium-antagonist-type cardiac effects of nifedipine in vitro and in vivo. Comparative experimental study].
Cosín J; Gimeno JV; Martín G; Ramírez A; Ferrer J; Báguena J
Rev Esp Cardiol; 1982; 35(5 Suppl 2):II115-22. PubMed ID: 7170402
[No Abstract] [Full Text] [Related]
43. Excitation-contraction coupling in cardiac and vascular smooth muscle: modification by calcium-entry blockade.
McCall D
Circulation; 1987 Jun; 75(6 Pt 2):V3-14. PubMed ID: 2436829
[TBL] [Abstract][Full Text] [Related]
44. Effects of a novel calcium channel agonist dihydropyridine analogue, Bay k 8644, on pig coronary artery: biphasic mechanical response and paradoxical potentiation of contraction by diltiazem and nimodipine.
Dubé GP; Baik YH; Schwartz A
J Cardiovasc Pharmacol; 1985; 7(2):377-89. PubMed ID: 2581094
[TBL] [Abstract][Full Text] [Related]
45. The effect of verapamil, diltiazem and nifedipine on baroreceptor reflexes.
Zsotér TT; Nebitko RL; Chow R
Clin Invest Med; 1988 Dec; 11(6):430-4. PubMed ID: 3229038
[TBL] [Abstract][Full Text] [Related]
46. Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine.
Zyvoloski MG; Brooks HL; Gross GJ; Warltier DC
J Pharmacol Exp Ther; 1982 Aug; 222(2):494-500. PubMed ID: 7097568
[TBL] [Abstract][Full Text] [Related]
47. Effects of calcium entry blockers on coronary constriction and myocardial ischemia due to leukotriene D4.
Ezra D; Boyd LM; Goldstein RE; Feuerstein G
J Pharmacol Exp Ther; 1985 Apr; 233(1):229-34. PubMed ID: 3981457
[TBL] [Abstract][Full Text] [Related]
48. Effects of hypoxia, elevated K+ and acidosis on the potency of verapamil, diltiazem and nifedipine in the guinea-pig isolated papillary muscle.
Robertson MJ; Lumley P
Br J Pharmacol; 1989 Nov; 98(3):937-49. PubMed ID: 2590774
[TBL] [Abstract][Full Text] [Related]
49. Comparative electrophysiologic effects of bepridil, verapamil and diltiazem in conscious and anesthetized dogs.
Kantelip JP; Alatienne M; Talmant JM; Ghyselinck N; Duchêne-Marullaz P
Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):5-18. PubMed ID: 3493741
[TBL] [Abstract][Full Text] [Related]
50. Effects of calcium-antagonistic coronary vasodilators on myocardial contractility and membrane potentials.
Nabata H
Jpn J Pharmacol; 1977 Apr; 27(2):239-49. PubMed ID: 886659
[TBL] [Abstract][Full Text] [Related]
51. Increased negative inotropic effect of calcium-channel blockers in hypertrophied and failing rabbit heart.
Ezzaher A; el Houda Bouanani N; Su JB; Hittinger L; Crozatier B
J Pharmacol Exp Ther; 1991 Apr; 257(1):466-71. PubMed ID: 1826929
[TBL] [Abstract][Full Text] [Related]
52. Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension.
Young TE; Lundquist LJ; Chesler E; Weir EK
Am J Cardiol; 1983 Jan; 51(1):195-200. PubMed ID: 6571766
[TBL] [Abstract][Full Text] [Related]
53. Hemodynamic profile of Ro 40-5967 in conscious rats: comparison with diltiazem, verapamil, and amlodipine.
Véniant M; Clozel JP; Hess P; Wolfgang R
J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S55-8. PubMed ID: 1725005
[TBL] [Abstract][Full Text] [Related]
54. Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha 2-adrenoceptor agonists by diltiazem and verapamil.
Cavero I; Shepperson N; Lefèvre-Borg F; Langer SZ
Circ Res; 1983 Feb; 52(2 Pt 2):I69-76. PubMed ID: 6131754
[TBL] [Abstract][Full Text] [Related]
55. Effects of four calcium channel blockers on central cardiovascular control.
Montastruc JL; Damase-Michel C; Dang-Tran L; Montastruc P
Arch Int Pharmacodyn Ther; 1989; 297():112-9. PubMed ID: 2730230
[TBL] [Abstract][Full Text] [Related]
56. Negative inotropic activity of the calcium antagonists isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardium.
Schwinger RH; Böhm M; Erdmann E
Am J Hypertens; 1991 Feb; 4(2 Pt 2):185S-187S. PubMed ID: 1827017
[TBL] [Abstract][Full Text] [Related]
57. Acute dilatory and negative inotropic effects of homocysteine are inhibited by an adenosine blocker.
Kennedy RH; Owings R; Joseph J; Melchert RB; Hauer-Jensen M; Boerma M
Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):340-4. PubMed ID: 16620298
[TBL] [Abstract][Full Text] [Related]
58. Differential effects of systemic and intracoronary calcium channel blocking agents on global and regional left ventricular function in conscious dogs.
Walsh RA; Badke FR; O'Rourke RA
Am Heart J; 1981 Sep; 102(3 Pt 1):341-50. PubMed ID: 6267919
[TBL] [Abstract][Full Text] [Related]
59. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].
Nakaya H
Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455
[TBL] [Abstract][Full Text] [Related]
60. In vitro and in vivo electrocardiographic evaluation of the novel calcium antagonist monatepil on cardiac conduction system.
Nose I; Kataoka T; Honda Y; Yamada T; Ikeno A; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T
Arzneimittelforschung; 1993 Jul; 43(7):722-8. PubMed ID: 8369002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
